Clinical Trial Update: Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy volunteers comparing once-daily PMR to twice-daily cilostazol immediate-release tablets has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication

Drugs mentioned

• PMR
• cilostazol IR (cilostazol)

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Intermittent Claudication | Phase 1 | Status: COMPLETED